デフォルト表紙
市場調査レポート
商品コード
1630775

熱傷軟膏の市場規模、シェア、成長分析:製品タイプ別、熱傷の種類別、最終用途別、地域別 - 産業予測 2025~2032年

Burn Ointment Market Size, Share, Growth Analysis, By Product (Topical Antibiotics, Silver), By Type of Burns (Minor Burns, Partial Thickness Burns), By End Use, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 219 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
熱傷軟膏の市場規模、シェア、成長分析:製品タイプ別、熱傷の種類別、最終用途別、地域別 - 産業予測 2025~2032年
出版日: 2025年01月09日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

熱傷軟膏の世界市場規模は2023年に17億米ドルと評価され、2024年の18億米ドルから2032年には28億7,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは6.0%で成長する見通しです。

世界の熱傷軟膏市場は、火傷の罹患率の上昇と最新の創傷ケアに対する意識の高まりに後押しされ、一貫した成長を遂げています。この拡大には、効果的で治癒の早い治療に対するニーズの高まり、熱傷治療技術の進歩、幅広い市販薬の選択肢などが不可欠な推進力となっています。市場参入企業は天然成分を配合した革新的な製剤にますます注力し、製品開発のために戦略的パートナーシップを結ぶようになっています。北米と欧州が市場を独占しており、これらの地域における強固なヘルスケアインフラと大規模な研究開発投資の恩恵を受けています。火傷の症例が世界的に増加し続けていることから、より安全で、より効率的で、利用しやすい熱傷軟膏ソリューションへの動向は明らかであり、市場はさらなる成長を遂げようとしています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析

熱傷軟膏市場規模:製品タイプ別& CAGR(2025-2032)

  • 市場概要
  • 外用抗生物質
  • 銀クリーム
  • ヨウ素
  • その他

熱傷軟膏市場規模:熱傷の種類別& CAGR(2025-2032)

  • 市場概要
  • 軽度の熱傷
  • 部分的熱傷
  • 全層熱傷

熱傷軟膏市場規模:最終用途別& CAGR(2025-2032)

  • 市場概要
  • 病院
  • クリニック
  • その他

熱傷軟膏市場規模:地域別& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • Johnson & Johnson(USA)
  • Pfizer Inc.(USA)
  • GlaxoSmithKline plc(UK)
  • Sanofi(France)
  • Bayer AG(Germany)
  • Sun Pharmaceutical Industries Ltd.(India)
  • Cipla Limited(India)
  • Mankind Pharma Ltd.(India)
  • Dr. Morepen Limited(India)
  • Smith & Nephew plc(UK)
  • ConvaTec Group plc(UK)
  • 3M Company(USA)
  • Cardinal Health(USA)
  • Medline Industries, LP(USA)
  • Coloplast A/S(Denmark)
  • Integra LifeSciences Corporation(USA)
  • PAUL HARTMANN AG(Germany)

結論と推奨事項

目次
Product Code: SQMIG35I2210

Global Burn Ointment Market size was valued at USD 1.7 billion in 2023 and is poised to grow from USD 1.8 billion in 2024 to USD 2.87 billion by 2032, growing at a CAGR of 6.0% during the forecast period (2025-2032).

The global burn ointment market is experiencing consistent growth, propelled by the rising incidence of burn injuries and heightened awareness of modern wound care. Essential drivers for this expansion include the increasing need for effective, rapid-healing treatments, advancements in burn care technology, and a wide range of over-the-counter options. Market participants are increasingly focusing on innovative formulations featuring natural ingredients and forming strategic partnerships for product development. Dominated by North America and Europe, the market benefits from robust healthcare infrastructure and significant R&D investment in these regions. As burn cases continue to rise worldwide, the market is set for further growth, with a clear trend toward safer, more efficient, and accessible burn ointment solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Burn Ointment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Burn Ointment Market Segmental Analysis

Global Burn Ointment Market is segmented by Product, Type of Burns, End Use and region. Based on Product, the market is segmented into Topical Antibiotics, Silver, Iodine and Others. Based on Type of Burns, the market is segmented into Minor Burns, Partial Thickness Burns and Full Thickness Burns. Based on End Use, the market is segmented into Hospitals, Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Burn Ointment Market

One of the key factors propelling the global burn ointment market is the surge in burn incidents, which can be attributed to a variety of causes including accidents, fire-related events, chemical spills, and other unforeseen mishaps. With the increasing frequency of such cases, there is a corresponding rise in the demand for effective burn ointments and related medical treatments. This growing prevalence of burn injuries not only highlights the necessity for advanced therapeutic solutions but also significantly drives the expansion and growth of the burn ointment market as healthcare providers and consumers seek reliable remedies for treatment.

Restraints in the Global Burn Ointment Market

The global burn ointment market faces several restraints, particularly stemming from regulatory challenges and safety concerns. Stringent oversight by health authorities necessitates thorough evaluations of medical products, including burn ointments, to guarantee their safety and efficacy. These rigorous approval processes can lead to significant delays in bringing products to market. Additionally, any emerging concerns regarding potential adverse effects can further exacerbate these delays and create barriers to market entry. Consequently, these regulatory hurdles pose a significant challenge to the growth and expansion of the burn ointment market, potentially impacting the availability of new and innovative treatment options for consumers.

Market Trends of the Global Burn Ointment Market

The global burn ointment market is experiencing a notable trend towards the incorporation of advanced wound care products, driven by an escalating demand for enhanced healing solutions. Both consumers and healthcare professionals are increasingly prioritizing formulations that deliver dual benefits: effective pain relief and robust infection prevention, alongside accelerated wound healing capabilities. This trend has spurred innovation, resulting in the launch of burn ointments infused with cutting-edge ingredients like growth factors, collagen, and bioactive compounds, which aim to stimulate tissue regeneration and minimize scarring. As awareness of these advanced products rises, the market is poised for sustained growth, reflecting the evolving needs of patients.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Burn Ointment Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Topical Antibiotics
  • Silver
  • Iodine
  • Others

Global Burn Ointment Market Size by Type of Burns & CAGR (2025-2032)

  • Market Overview
  • Minor Burns
  • Partial Thickness Burns
  • Full Thickness Burns

Global Burn Ointment Market Size by End Use & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Clinics
  • Others

Global Burn Ointment Market Size & CAGR (2025-2032)

  • North America (Product, Type of Burns, End Use)
    • US
    • Canada
  • Europe (Product, Type of Burns, End Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Type of Burns, End Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Type of Burns, End Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Type of Burns, End Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Johnson & Johnson (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sun Pharmaceutical Industries Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cipla Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mankind Pharma Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dr. Morepen Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smith & Nephew plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ConvaTec Group plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 3M Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medline Industries, LP (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Coloplast A/S (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integra LifeSciences Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PAUL HARTMANN AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations